Water Extract of Curcuma longa L. Ameliorates Non-Alcoholic Fatty Liver Disease

被引:67
|
作者
Mun, Jeongeun [1 ]
Kim, Shintae [1 ]
Yoon, Ho-Geun [2 ]
You, Yanghee [1 ]
Kim, Ok-Kyung [1 ]
Choi, Kyung-Chul [3 ]
Lee, Yoo-Hyun [4 ]
Lee, Jeongmin [5 ]
Park, Jeongjin [1 ]
Jun, Woojin [1 ]
机构
[1] Chonnam Natl Univ, Div Food & Nutr, Gwangju 61186, South Korea
[2] Yonsei Univ, Coll Med, Dept Biochem & Mol Biol, Seoul 03722, South Korea
[3] Univ Ulsan, Dept Biomed Sci, Coll Med, Seoul 05505, South Korea
[4] Univ Suwon, Dept Food & Nutr, Gyeonggido 18323, South Korea
[5] Kyung Hee Univ, Dept Med Nutr, Gyeonggido 17104, South Korea
基金
新加坡国家研究基金会;
关键词
Curcuma longa L; non-alcoholic fatty liver disease; fatty acid uptake; lipid accumulation; oxidative stress; INDUCED OXIDATIVE STRESS; ANTIOXIDANT; DIET; EXPRESSION; PURIFICATION; GLUTATHIONE; RESISTANT; TRENDS; RATS;
D O I
10.3390/nu11102536
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Our aim was to investigate whether hot water extract (CLW) of Curcuma longa L. could prevent non-alcoholic fatty liver disease (NAFLD). HepG2 cells were treated with free fatty acid (FFA) mixture (oleic acid: palmitic acid, 2:1) for 24 h to stimulate in vitro fatty liver. In addition, C57BL/6 mice were fed 60 kcal% high-fat (HF) diet for eight weeks to induce fatty liver in vivo. Intracellular reactive oxygen species (ROS) and malondialdehyde (MDA) productions were increased by FFA and HF-diet, but supplementation with CLW significantly decreased these levels. CLW treatment ameliorated antioxidant activities that were suppressed by exposure to the FFA and HF-diet. Cluster of differentiation 36 (CD36) and fatty acid transport proteins (FATP2 and FATP5) were increased in HF-diet groups, while CLW suppressed their expression levels. Moreover, sterol regulatory element-binding protein-1c (SREBP-1c), acetyl-coenzyme A carboxylase (ACC), and fatty acid synthase (FAS) expression levels were down-regulated in the CLW groups compared to HF-diet groups. On the other hand, 5 ' adenosine monophosphate-activated protein kinase (AMPK), Peroxisome proliferator-activated receptor alpha (PPAR-alpha), and carnitine palmitoyltransferase 1 (CPT-1) expressions were up-regulated in the CLW groups. HF-diet fed mice showed high hepatic triglycerides (TG) content compared to the normal diet mice. However, the administration of CLW restored the hepatic TG level, indicating an inhibitory effect against lipid accumulation by CLW. These results suggest that CLW could be a potentially useful agent for the prevention of NAFLD through modulating fatty acid uptake.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] CEUS and Fibroscan in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
    Sila Cocciolillo
    Giustino Parruti
    Leonardo Marzio
    World Journal of Hepatology, 2014, (07) : 496 - 503
  • [42] Lifestyle Modifications in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
    Stavropoulos, Konstantinos
    Imprialos, Konstantinos
    Pittaras, Andreas
    Faselis, Charles
    Narayan, Puneet
    Kokkinos, Peter
    CURRENT VASCULAR PHARMACOLOGY, 2018, 16 (03) : 239 - 245
  • [43] Non-alcoholic fatty liver disease (NAFLD). Non-alcoholic steatohepatitis - NASH
    Keller, KM
    MONATSSCHRIFT KINDERHEILKUNDE, 2004, 152 (08) : 864 - 869
  • [44] An update on non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Asia
    Hsu, Ching-Sheng
    Kao, Jia-Horng
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 11 (08) : 759 - 772
  • [45] Surgical Treatment of Non-Alcoholic Steatohepatitis and Non-Alcoholic Fatty Liver Disease
    Weiner, R. A.
    DIGESTIVE DISEASES, 2010, 28 (01) : 274 - 279
  • [46] Pathology of non-alcoholic fatty liver disease
    Bedossa, Pierre
    LIVER INTERNATIONAL, 2017, 37 : 85 - 89
  • [47] The epidemiology of non-alcoholic fatty liver disease
    Bellentani, Stefano
    LIVER INTERNATIONAL, 2017, 37 : 81 - 84
  • [48] Non-alcoholic fatty liver disease in children
    Chaturvedi, Kanupriya
    Vohra, Pankaj
    INDIAN PEDIATRICS, 2012, 49 (09) : 757 - 758
  • [49] Non-alcoholic fatty liver disease and diabetes
    Reyes-Garcia, Rebeca
    Rozas-Moreno, Pedro
    Julio Llamoza-Torres, Camilo
    Mezquita-Raya, Pedro
    MEDICINA CLINICA, 2017, 148 (01): : 33 - 38
  • [50] Mitochondria in non-alcoholic fatty liver disease
    Prip-Buus, C.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2016, 46 : 53 - 53